Brind.

Semerjian worked at Novartis for 17 years.

1 report, 1 independent Updated Aug 18

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Novartis Geron Corporation

Keep exploring

The entities involved

Novartis
Swiss-American multinational pharmaceutical corporation
- Novartis acquired Avidity in a $12 billion purchase, while Trump simultaneously threatened Swiss businesses with tariffs.Sat 01:46
- GSK and Novartis are identified as major pharmaceutical companies.Fri 02:16
Geron Corporation
company

Nothing else this week.

Related events

Coverage

Newest first; wire copies grouped

Aug 18Insider MonkeyGeron Corporation Names Harout Semerjian as New CEO to Lead Commercialization of RYTELO Geron Corporation (NASDAQ:GERN) is one of the most promising penny stocks under $5. On August 6, Geron Corporat